This Antibody was verified by Relative expression to ensure that the antibody binds to the antigen stated. View Details
MA5-12023 targets Glial Fibrillary Acidic Protein in IF, IHC (P), and WB applications and shows reactivity with Chicken, Human, Porcine, and Rat samples.
The MA5-12023 immunogen is glial Fibrillary Acidic Protein.
MA5-12023 was successfully used to detect astrocytes in E18 Sparague Dawley primary cortical cells.
GFAP (Glial fibrillary acidic protein) is a member of the class III intermediate filament protein family. GFAP is heavily, and specifically, expressed in astrocytes and certain astroglia in the central nervous system, in satellite cells in peripheral ganglia, and in non-myelinating Schwann cells in peripheral nerves. In addition, neural stem cells strongly express GFAP. Antibodies to GFAP are very useful as markers of astrocytic cells. In addition, many types of brain tumor, presumably derived from astrocytic cells, heavily express GFAP. GFAP is also found in the lens epithelium, Kupffer cells of the liver, in some cells in salivary tumors and has been reported in erythrocytes. GFAP is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing of the GFAP gene results in multiple transcript variants encoding distinct isoforms.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: 65 kDa glutamic acid decarboxylase; GAD-65; GFAP; Glial fibrillary acidic protein; glial fibrillary acidic protein alpha; Glutamate decarboxylase 2; Glutamate decarboxylase 65 kDa isoform; intermediate filament
Gene Aliases: 6330404F12Rik; ALXDRD; GAD(65); Gad-2; Gad2; GAD65; GFAP